Author

Philippe Bourassa

Université Laval

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Cyntia TremblayiD· 3 shared David Alan BennettiD· 2 shared Frédéric CaloniD· 2 shared Louise Réveret· 2 shared A Loiselle· 1 shared Ádám InstitórisiD· 1 shared Andrew P. BrauniD· 1 shared Andréy S. ShawiD· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Cyntia TremblayORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

Louise Réveret, Leclerc Manon, Emond Vincent, A Loiselle, Philippe Bourassa, Cyntia Tremblay, David A. A Bennett, Hébert Sébastien, Calon Frédéric

This study finds higher ACE2 levels in the brains of Alzheimer's patients, which may increase CNS SARS-CoV-2 infection risk.

bioRxiv · Jan 17, 2023 · PreprintNeuroscience

Cerebrovascular insulin receptors are defective in Alzheimer's disease

M. Leclerc, Philippe Bourassa, Cyntia Tremblay, Vicky Caron, Camille Sugère, Vincent Émond, David Alan Bennett, Frédéric Calon

The paper shows that insulin receptors in microvessels at the blood-brain barrier are defective in Alzheimer's disease, contributing to brain insulin resistance and cognitive impairment.

bioRxiv · Dec 1, 2021 · PreprintNeuroscience

The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network

Milène Vandal, Ádám Institóris, Ben Korin, Colin Gunn, Suzie Lee, Ji Yeon Lee, Philippe Bourassa, Ramesh C. Mishra, Govind Peringod, Yulan Jiang, Sotaro Hirai, Camille Belzil, Louise Réveret, Cyntia Tremblay, Mada Hashem, , Minh Dang Nguyen

This study shows that CD2AP loss in brain endothelial cells impairs vascular function and memory in AD models, suggesting therapeutic targeting of CD2AP pathways.

bioRxiv · Dec 10, 2020 · PreprintNeuroscience